SCHEMBL13745266

SCHEMBL13745266

C=CCN1CC(=O)N2C(Cc3ccc(O)cc3)C(=O)N(Cc3ccc(F)cc3F)C[C@H]2N1C(=O)NCc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL747910 1.00 CYP3A4 (0.66) CYP3A4
SCHEMBL748397 1.00 CYP3A4 (0.66) CYP3A4
SCHEMBL2875135 1.00 CYP3A4 (0.66) CYP3A4
SCHEMBL12156642 1.00 CYP3A4 (0.66) CYP3A4
SCHEMBL748794 1.00 CYP3A4 (0.66) CYP3A4
SCHEMBL748193 0.96 CYP3A4 (0.61) CYP3A4
SCHEMBL13028780 0.95 CYP3A4 (0.59) CYP3A4
SCHEMBL748931 0.94 CYP3A4 (0.59) CYP3A4
SCHEMBL10291362 0.94 CYP3A4 (0.58) CYP3A4
SCHEMBL12154867 0.93 CYP3A4 (0.65) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION MYLK2, TNNC1, MYH2 CYP3A4 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.